2
Clinical Trials associated with SII Yellow Fever Vaccine(Serum Institute of India)A Phase III, Multicenter, Double Blind, Randomized Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants
The study is designed as a Phase III, double-blind, multi-center, randomized, active-controlled study in which four groups of participants (n=554 per group) will receive either one of three different manufacturing lots of SII-YFV or STAMARIL® - a licensed and WHO pre-qualified YFV.
An Open-Label, Randomized, Active Controlled, Phase I Clinical Study to Assess the Safety and Tolerability of SII Yellow Fever Vaccine in Healthy Adults.
100 Clinical Results associated with SII Yellow Fever Vaccine(Serum Institute of India)
100 Translational Medicine associated with SII Yellow Fever Vaccine(Serum Institute of India)
100 Patents (Medical) associated with SII Yellow Fever Vaccine(Serum Institute of India)
100 Deals associated with SII Yellow Fever Vaccine(Serum Institute of India)